Results 1 to 10 of about 2,774 (159)

Micropulse Transscleral Cyclophotocoagulation for Glaucoma after Penetrating Keratoplasty

open access: yesDiagnostics, 2022
The main objective of the article was to assess the surgical outcome of micropulse transscleral cyclophotocoagulation in patients presenting with glaucoma after penetrating keratoplasty.
Daniel Constantin Branisteanu   +2 more
exaly   +4 more sources

Topical Anesthesia Offers Sufficient Pain Control for MicroPulse Transscleral Laser Therapy for Glaucoma

open access: yesJournal of Ophthalmology, 2022
Introduction. The aim of this study was to evaluate patient pain during and after MicroPulse Transscleral Laser Therapy (TLT) and vision-related quality of life using two different anesthesia protocols: “Topical Plus” anesthesia without standby ...
Belgin Vasella, Marc Töteberg-Harms
doaj   +2 more sources

The efficacy of MicroPulse Transscleral Laser Therapy as primary surgical treatment in various types of glaucoma resistant to medical treatment: a retrospective analysis [PDF]

open access: yesBMC Ophthalmology
Purpose To evaluate the results of MicroPulse Transscleral Laser Therapy (TLT) as primary treatment in various types of glaucoma resistant to medical treatment.
Müslüm Toptan, Omer Faruk Yilmaz
doaj   +2 more sources

Micropulse Laser Therapy as an Integral Part of Eye Disease Management

open access: yesMedicina (Lithuania), 2023
Ocular diseases can significantly impact vision and quality of life through pathophysiological alterations to the structure of the eye. The management of these conditions often involves a combination of pharmaceutical interventions, surgical procedures ...
Vesa Cosmin Mihai   +2 more
exaly   +3 more sources

A case of macular damage following micropulse laser treatment for central serous chorioretinopathy [PDF]

open access: yesJournal of International Medical Research
Subthreshold micropulse laser treatment has proven to be an effective treatment for central serous chorioretinopathy. We report a rare case of localized macular damage following 577-nm subthreshold micropulse laser therapy in a patient with central ...
Jianli Wei, Lishuang Chen
doaj   +2 more sources

Efficacy of pan retinal photocoagulation sub- threshold micropulse diode laser in diabetic retinopathy [PDF]

open access: yesAl-Azhar International Medical Journal, 2021
Background: Diabetic retinopathy occurs as a complication of systemic diabetes . The potential use of laser for the treatment of severe non proliferative diabetic retinopathy (SNPDR) and early PDR provides another dimension in the management due to its ...
Mohammad Abbas   +2 more
doaj   +1 more source

Efficacy and safety of subliminal transscleral cyclophotocoagulation in uncontrolled glaucoma

open access: yesIndian Journal of Ophthalmology, 2022
Purpose: To determine the efficacy of subliminal cyclophotocoagulation in reducing intraocular pressure (IOP) and to assess the safety profile of the procedure.
Ferzana Mohammed   +3 more
doaj   +1 more source

Lasers in Medicine: The Changing Role of Therapeutic Laser-Induced Retinal Damage—From de rigeuer to Nevermore

open access: yesPhotonics, 2023
For over five decades, laser-induced retinal damage (LIRD) was thought to be the necessary cost of all therapeutic effects of laser treatment for the most important causes of irreversible visual loss, the chronic progressive retinopathies (CPRs).
Jeffrey K. Luttrull
doaj   +1 more source

Comparative study between subthreshold (micropulse) laser direct application to the edematous macula versus direct application to the peripheral healthy retina in the treatment of diabetic macular edema. [PDF]

open access: yesAl-Azhar International Medical Journal, 2023
Background: Subthreshold (micropulse) laser is an effective modality in the treatment of diabetic macular edema that avoids possible complications of conventional laser photocoagulation and anti-vascular endothelial growth factor. Regardless of where the
Eslam Alharif, Hamed Taha, Mohamed Rahed
doaj   +1 more source

Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT

open access: yesHealth Technology Assessment, 2022
Background: The National Institute for Health and Care Excellence recommends macular laser to treat diabetic macular oedema with a central retinal subfield thickness of  400 µm.
Noemi Lois   +26 more
doaj   +1 more source

Home - About - Disclaimer - Privacy